{{Rsnum
|rsid=3743162
|Gene=SLC28A1
|Chromosome=15
|position=84887738
|Orientation=plus
|GMAF=0.1575
|Gene_s=SLC28A1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 63.7 | 30.1 | 6.2
| HCB | 62.8 | 33.6 | 3.6
| JPT | 72.6 | 25.7 | 1.8
| YRI | 100.0 | 0.0 | 0.0
| ASW | 87.7 | 12.3 | 0.0
| CHB | 62.8 | 33.6 | 3.6
| CHD | 78.9 | 19.3 | 1.8
| GIH | 78.2 | 19.8 | 2.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 60.3 | 31.0 | 8.6
| MKK | 92.3 | 7.7 | 0.0
| TSI | 71.6 | 24.5 | 3.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22005931
|Trait=None
|Title=Genome-wide association analysis of age-at-onset in Alzheimer's disease.
|RiskAllele=
|Pval=0.000009
|OR=None
|ORtxt=None
|OA=1
}}

{{PMID Auto
|PMID=19898621
|Title=Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}